Histopathological growth pattern of liver metastases as an independent marker of metastatic behavior in different primary cancers
Authors:
- Ali BohlokABAli Bohlok
- François RichardFRFrançois Richard
- Valerio LucidiVLValerio Lucidi
- Antoine El AsmarAAAntoine El Asmar
- Pieter DemetterPDPieter Demetter
- Ligia CraciunLCLigia Craciun
- Denis LarsimontDLDenis Larsimont
- Alain HendliszAHAlain Hendlisz
- Jean Luc Van LaethemJLJean Luc Van Laethem
- Luc DirixLDLuc Dirix
- Christine DesmedtCDChristine Desmedt
- Peter VermeulenPVPeter Vermeulen
Open Access
- 27 October 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 13, 1260880
Abstract
Surgical resection can lead to prolonged survival in patients with isolated liver metastases (LM) from various primary cancers. However, there are currently no validated predictive markers to discriminate between these oligo/argometastatic patients, who will benefit from surgery, and those with diffuse metastatic behavior in whom surgery will be futile. To evaluate whether the tumor microenvironment, or histopathological growth pattern (HGP), of LM reflects the type of metastatic progression independently of the origin of the primary cancer, we analyzed a combined series of patients who underwent surgery for colorectal LM (N=263) or non-colorectal LM (N=66). HGPs of LM were scored in each patient to distinguish between desmoplastic HGP (all LM showing a complete encapsulated pattern) and non-desmoplastic HGP (at least one LM with some infiltrating-replacement component). In the entire series, 5-year overall and progression-free survival were, 44.5% and 15.5%, respectively, with no significant differences between colorectal and non-colorectal LM. In patients with desmoplastic HGP, 5-year overall and progression-free survival were 57% and 32%, respectively, as compared to 41% and 12%, respectively, in patients with non-desmoplastic-HGP (p=0.03 and 0.005). Irrespective of cancer origin and compared to traditional risk factors, desmoplastic HGP was the most significant predictor for better post-operative overall survival (adjusted HR: 0.62; 95% CI: [0.49-0.97]; p=0.035) and progression-free survival (adjusted HR: 0.61; 95% CI: [0.42-0.87], p=0.006). This suggests that the HGP of LM may represent an accurate marker that reflects the mode of metastatic behavior, independently of primary cancer type.Keywords
This publication has 38 references indexed in Scilit:
- Is Hepatic Resection for Non-colorectal, Non-neuroendocrine Liver Metastases Justified?Annals of Surgical Oncology, 2015
- Early Recurrence After Liver Resection for Colorectal Metastases: Risk Factors, Prognosis, and Treatment. A LiverMetSurvey-Based Study of 6,025 PatientsAnnals of Surgical Oncology, 2013
- Improving the clinical risk score: An analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastasesSurgery, 2012
- Is the Clinical Risk Score for Patients with Colorectal Liver Metastases Still Useable in the Era of Effective Neoadjuvant Chemotherapy?Annals of Surgical Oncology, 2011
- Oligometastases revisitedNature Reviews Clinical Oncology, 2011
- Predictors of early disease recurrence following hepatic resection for colorectal cancer metastasisEuropean Journal of Surgical Oncology, 2007
- Hepatic Resection for Noncolorectal Nonendocrine Liver MetastasesTransactions of the ... Meeting of the American Surgical Association, 2006
- Changes in Indication and Results After Resection of Hepatic Metastases From Noncolorectal Primary Tumors: A Single-Institutional ReviewAnnals of Surgical Oncology, 2005
- One Thousand Fifty-Six Hepatectomies Without Mortality in 8 YearsArchives of Surgery, 2003
- Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasiaThe Journal of Pathology, 2001